Cost Curve News - News - https://www.costcurvenews.com/blog/page/3/

What Yesterday’s RFK Jr. Hearing Did — and Did Not — Illuminate

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

More on the Biggest Story of Fall 2025: The Growth in Health Care Spending

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

The Many Twists in the Gordian Knot that Is Obesity-Med Coverage

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

Tariffs Are Illegal (Maybe) … But That Might Not Matter for Meds

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

Turmoil at the CDC Means that Vaccine Access Is Already Being Impacted in a Real Way

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

Novo’s Latest Pharm-to-Table Deals Show How the Trend Is Evolving into an Ecosystem

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

People Are Getting Real Nervous About Premium Increases

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

The UK Is Suddenly a Flashpoint in the Battle Over Price and Access

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

Examining the Latest Launch Price: Ionis’ Dawnzera

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

1 month ago

Keep Reading

Cost Curve News

European Tariffs — As Expected — Come in at 15%, But the Trade Deal Protects Against Even Bigger Levies

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

What Yesterday’s RFK Jr. Hearing Did — and Did Not — Illuminate

More on the Biggest Story of Fall 2025: The Growth in Health Care Spending

The Many Twists in the Gordian Knot that Is Obesity-Med Coverage

Tariffs Are Illegal (Maybe) … But That Might Not Matter for Meds

Turmoil at the CDC Means that Vaccine Access Is Already Being Impacted in a Real Way

Novo’s Latest Pharm-to-Table Deals Show How the Trend Is Evolving into an Ecosystem

People Are Getting Real Nervous About Premium Increases

The UK Is Suddenly a Flashpoint in the Battle Over Price and Access

Examining the Latest Launch Price: Ionis’ Dawnzera

European Tariffs — As Expected — Come in at 15%, But the Trade Deal Protects Against Even Bigger Levies

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Latest News

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

Subcribe To Newsletter